Skip to main content Accessibility Statement

Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

--

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events

More events are coming soon.

Recent News

  • May 6, 2024

    Tactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results

    Reaffirms Full Year 2024 Outlook MINNEAPOLIS , May 06, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first

    Read more

  • April 23, 2024

    Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue

    CEO Dan Reuvers to retire; Healthcare veteran and board director Sheri Dodd appointed as Chief Executive Officer Preliminary, unaudited total revenue for first quarter of 2024 expected to be approximately $61 million Management to host conference call on May 6, 2024 to discuss first quarter 2024

    Read more

  • April 15, 2024

    Tactile Medical to Release First Quarter of Fiscal Year 2024 Financial Results on May 6, 2024

    MINNEAPOLIS , April 15, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2024 financial results will be

    Read more